Cancer vaccines

被引：440

作者：

Pardoll, DM ^{[1
]}

机构：

[1] Johns Hopkins Oncol Ctr, Baltimore, MD 21205 USA

来源：

NATURE MEDICINE | 1998年 / 4卷 / 05期

关键词：

D O I：

10.1038/nm0598supp-525

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Drew Pardoll (Johns Hopkins Oncology Center) examines prospects for therapeutic cancer vaccines. Considering how it is that the immune system fails to recognize and destroy cancer cells, Pardoll discusses contemporary vaccine approaches aimed at exposing cancer antigens to the cellular arm of the immune system, and the first, promising steps toward therapeutic cancer vaccines.

引用

收藏

页码：525 / 531

页数：7

相关论文

共 128 条

[21] IDENTIFICATION OF A PEPTIDE RECOGNIZED BY 5 MELANOMA-SPECIFIC HUMAN CYTOTOXIC T-CELL LINES [J].

COX, AL ;

SKIPPER, J ;

CHEN, Y ;

HENDERSON, RA ;

DARROW, TL ;

SHABANOWITZ, J ;

ENGELHARD, VH ;

HUNT, DF ;

SLINGLUFF, CL .

SCIENCE, 1994, 264 (5159) :716-719

[22]

COX WI, 1992, RECOMBINANT POXVIRUS, P123

[23] T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection [J].

deGruijl, TD ;

Bontkes, HJ ;

Stukart, MJ ;

Walboomers, JMM ;

Remmink, AJ ;

Verheijen, RHM ;

Helmerhorst, TJM ;

Meijer, CJLM ;

Scheper, RJ .

JOURNAL OF GENERAL VIROLOGY, 1996, 77 :2183-2191

[24] Oncogenic proteins as tumor antigens [J].

Disis, ML ;

Cheever, MA .

CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (05) :637-642

[25] VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].

DRANOFF, G ;

JAFFEE, E ;

LAZENBY, A ;

GOLUMBEK, P ;

LEVITSKY, H ;

BROSE, K ;

JACKSON, V ;

HAMADA, H ;

PARDOLL, D ;

MULLIGAN, RC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543

[26] THE INTERACTION OF BACTERIA WITH MAMMALIAN-CELLS [J].

FALKOW, S ;

ISBERG, RR ;

PORTNOY, DA .

ANNUAL REVIEW OF CELL BIOLOGY, 1992, 8 :333-363

[27]

FEARON ER, 1988, CANCER RES, V48, P2975

[28] VACCINATION WITH CYTOTOXIC T-LYMPHOCYTE EPITOPE-CONTAINING PEPTIDE PROTECTS AGAINST A TUMOR-INDUCED BY HUMAN PAPILLOMAVIRUS TYPE-16-TRANSFORMED CELLS [J].

FELTKAMP, MCW ;

SMITS, HL ;

VIERBOOM, MPM ;

MINNAAR, RP ;

DEJONGH, BM ;

DRIJFHOUT, JW ;

TERSCHEGGET, J ;

MELIEF, CJM ;

KAST, WM .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2242-2249

[29] Priming of cytotoxic T lymphocytes by DNA vaccines: Requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes [J].

Fu, TM ;

Ulmer, JB ;

Caulfield, MJ ;

Deck, RR ;

Friedman, A ;

Wang, S ;

Liu, X ;

Donnelly, JJ ;

Liu, MA .

MOLECULAR MEDICINE, 1997, 3 (06) :362-371

[30]

GISSMANN L, 1986, CIBA F SYMP, V120, P190

← 1 2 3 4 5 6 7 8 9 10 →